STOCK TITAN

Rani Therapeutics Holdings, Inc. (RANI) Free Cash Flow by Year

RANI

Rani Therapeutics Holdings, Inc. recorded an outflow of $18.8M in free cash flow in fiscal year 2025. This represents an increase of 47.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to an outflow of $20.3M in free cash flow. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Rani Therapeutics Holdings, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$18.8M
YoY +47.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RANI Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Free Cash Flow-$20.3M-$18.8M+47.4%-$35.8M+31.8%-$52.5M-9.0%-$48.1M-47.0%-$32.8M-102.7%-$16.2M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

RANI Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash Flow-$9.1M-55.3%-$6.5M+20.6%$294K+103.4%-$5.1M+40.7%-$5.8M+36.1%-$8.2M+13.0%-$8.7M+31.3%-$8.5M+42.3%-$9.1M+27.8%-$9.4M+24.0%-$12.6M+16.6%-$14.8M-16.8%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Rani Therapeutics Holdings, Inc. financials

Frequently Asked Questions

What was Rani Therapeutics Holdings, Inc.'s free cash flow in fiscal year 2025?

Rani Therapeutics Holdings, Inc. recorded an outflow of $18.8M in free cash flow in fiscal year 2025.

How fast is Rani Therapeutics Holdings, Inc.'s free cash flow growing?

Rani Therapeutics Holdings, Inc. (RANI) free cash flow rose by 47.4% year over year, from -$35.8M to -$18.8M in fiscal year 2025.

What is Rani Therapeutics Holdings, Inc.'s free cash flow over the last twelve months?

Rani Therapeutics Holdings, Inc. (RANI) reported an outflow of $20.3M in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 6 fiscal years this page covers, Rani Therapeutics Holdings, Inc. (RANI) free cash flow went from -$16.2M in fiscal year 2020 to -$18.8M in fiscal year 2025.

Rani Therapeutics Holdings, Inc. (RANI) reported -$9.1M in free cash flow in Q2 2026. This represents a decrease of 55.3% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Rani Therapeutics Holdings, Inc. (RANI) reported on that line in every period on record.